Startseite/Aktien/ARTV

ARTV

USD

Artiva Biotherapeutics Inc. Common Stock

$3.550-0.010 (-0.281%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$3.560

Hoch

$3.680

Tief

$3.510

Volumen

0.12M

Unternehmensfundamentaldaten

Marktkapitalisierung

86.7M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

2.12M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $1.47Aktuell $3.550Hoch $13.845

Ähnliche Nachrichten

3. Nov. 2025 · 21:05

GlobeNewswire

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

The virtual webcast will take place Wednesday, November 12, 2025, at 8 a.m. ET Initial safety data for 32 patients with autoimmune disease treated with AlloNK + monoclonal antibody (mAb) therapy, highlighting a

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

30. Okt. 2025 · 20:17

GlobeNewswire

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients